Would you have Lobular capillary hemangioma (Pyogenic granuloma) when you have Diabetes?
Summary: Lobular capillary hemangioma is reported only by a few people with Diabetes.
We study people who have Lobular capillary hemangioma (Pyogenic granuloma) and Diabetes from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
You are not alone: join a support group for people who have Diabetes and Lobular capillary hemangioma >>>
Diabetes can be treated by Metformin Hydrochloride, Glipizide, Actos, Lantus, Byetta, Victoza. (latest reports from 130,317 Diabetes patients)
Lobular capillary hemangioma
Lobular capillary hemangioma (a benign vascular tumour of the skin or mucous membranes) has been reported by people with osteoporosis, breast cancer, acne, rheumatoid arthritis, osteopenia. (latest reports from 284 Lobular capillary hemangioma patients)
On Mar, 29, 2015: 1 people who has diabetes and Lobular Capillary Hemangioma is studied.
Gender of people who have diabetes and experienced Lobular capillary hemangioma * :
|Lobular capillary hemangioma||100.00%||0.00% |
Age of people who have diabetes and experienced Lobular capillary hemangioma * :
|Lobular capillary hemangioma||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||100.00% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Pain (1 people, 100.00%)
- Diabetes mellitus (1 people, 100.00%)
- Musculoskeletal pain (1 people, 100.00%)
- Thyroid disorder (1 people, 100.00%)
Most common drugs used by these people * :
- Feldene (1 people, 100.00%)
- Glucophage (1 people, 100.00%)
- Lortab (1 people, 100.00%)
- Synthroid (1 people, 100.00%)
- Premarin (1 people, 100.00%)
- Lexapro (1 people, 100.00%)
- Tenoretic 50 (1 people, 100.00%)
- Seroquel (1 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Diabetes and Lobular Capillary Hemangioma?
You are not alone! Join a support group on :
- support group for people who have Lobular Capillary Hemangioma and Diabetes
- support group for people who have Diabetes
- support group for people who have Lobular Capillary Hemangioma
Could your drug cause:
Other conditions that could cause:
- A study of drug interactions between Ortho Tri-cyclen Lo, Multivitamin, Sertraline, Humalog, Lantus, Amlodipine, Losartan for a 34-year old woman with Birth Control, Health, Depression, Diabetes Mellitus, High Blood Pressure. The patient has Nightmares
- A study of drug interactions between Rosuvastatin Calcium, Metformin, Gliclazide for a 81-year old man with Diabetes. The patient has Diabetes
- A study of side effects of Novolog for a 16-year old boy with Diabetes. The patient has Edema - Peripheral, Peripheral Edema
- A study of side effects of Victoza for a 43-year old man with Diabetes. The patient has Tic - Facial
- A study of drug interactions between Macrobid, Effexor Xr, Metformin for a 58-year old woman with Urinary Tract Infection, Depression, Diabetes. The patient has Vomiting, Night Sweats, Urge Incontinence, Ear Congestion, Cough, Chest Ct, Scan Lymph Nodes
Recent Diabetes related drug comparison:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.